Literature DB >> 24080178

Hippocampal and cortical atrophy in amyloid-negative mild cognitive impairments: comparison with amyloid-positive mild cognitive impairment.

Byoung Seok Ye1, Sang Won Seo, Chi Hun Kim, Seun Jeon, Geon Ha Kim, Young Noh, Hanna Cho, Cindy W Yoon, Hee Jin Kim, Eun Young Jang, Jeongmin Lee, Jung-Hyun Kim, Juhee Chin, Jong Min Lee, Jeong-Hun Kim, Joon-kyung Seong, Chang-Hun Kim, Yearn Seong Choe, Kyung Han Lee, Duk L Na.   

Abstract

Although patients with amnestic mild cognitive impairment (aMCI) are at higher risk of developing Alzheimer's disease (AD), their pathologies could be heterogeneous. We aimed to evaluate structural changes in amyloid-negative and amyloid-positive aMCI patients. Forty-eight aMCI patients who underwent Pittsburgh compound B (PiB) positron emission tomography were recruited. They were classified as PiB (-) aMCI (N = 16) and PiB (+) (N = 32). Hippocampal shape and regional cortical thickness were compared with 41 subjects with normal cognition (NC). Relative to NC, PiB(-) aMCI exhibited hippocampal deformity in the right cornu ammonis 1, whereas PiB(+) aMCI exhibited hippocampal deformity in bilateral subiculum and cornu ammonis 1 subregions. Relative to NC, PiB(-) aMCI showed cortical thinning in the left medial prefrontal and right anterior temporal regions, whereas PiB(+) aMCI exhibited cortical thinning in bilateral medial temporal regions, temporoparietal junctions and precuneus, and prefrontal cortices. Our findings suggest that structural changes in PiB(-) aMCI might be due to several possible pathologic changes, whereas structural changes in PiB(+) aMCI reflect AD-like structural changes.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Cortical thickness; Hippocampus; Mild cognitive impairment; Pittsburgh compound B

Mesh:

Substances:

Year:  2013        PMID: 24080178     DOI: 10.1016/j.neurobiolaging.2013.08.017

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  10 in total

1.  Glucose Dysregulation Interacts With APOE-∊4 to Potentiate Temporoparietal Cortical Thinning.

Authors:  Jessica M Foley; David H Salat; Nikki H Stricker; Regina E McGlinchey; William P Milberg; Laura J Grande; Elizabeth C Leritz
Journal:  Am J Alzheimers Dis Other Demen       Date:  2015-05-24       Impact factor: 2.035

2.  Predictive Scale for Amyloid PET Positivity Based on Clinical and MRI Variables in Patients with Amnestic Mild Cognitive Impairment.

Authors:  Min Young Chun; Geon Ha Kim; Hee Kyung Park; Dong Won Yang; SangYun Kim; Seong Hye Choi; Jee Hyang Jeong
Journal:  J Clin Med       Date:  2022-06-15       Impact factor: 4.964

3.  Decreased hippocampal metabolism in high-amyloid mild cognitive impairment.

Authors:  Bernard J Hanseeuw; Aaron P Schultz; Rebecca A Betensky; Reisa A Sperling; Keith A Johnson
Journal:  Alzheimers Dement       Date:  2016-07-13       Impact factor: 21.566

4.  Subjective memory complaints, cortical thinning, and cognitive dysfunction in middle-aged adults at risk for AD.

Authors:  Stephanie A Schultz; Jennifer M Oh; Rebecca L Koscik; N Maritza Dowling; Catherine L Gallagher; Cynthia M Carlsson; Barbara B Bendlin; Asenath LaRue; Bruce P Hermann; Howard A Rowley; Sanjay Asthana; Mark A Sager; Sterling C Johnson; Ozioma C Okonkwo
Journal:  Alzheimers Dement (Amst)       Date:  2015-03-01

5.  Qualitative and quantitative assessment of self-reported cognitive difficulties in nondemented elders: Association with medical help seeking, cognitive deficits, and β-amyloid imaging.

Authors:  Renaud La Joie; Audrey Perrotin; Stéphanie Egret; Florence Pasquier; Clémence Tomadesso; Florence Mézenge; Béatrice Desgranges; Vincent de La Sayette; Gaël Chételat
Journal:  Alzheimers Dement (Amst)       Date:  2016-12-18

6.  Morphological and Microstructural Changes of the Hippocampus in Early MCI: A Study Utilizing the Alzheimer's Disease Neuroimaging Initiative Database.

Authors:  Peter Lee; Hojin Ryoo; Jinah Park; Yong Jeong
Journal:  J Clin Neurol       Date:  2017-01-25       Impact factor: 3.077

7.  Neuropsychology and neuroimaging profiles of amyloid-positive versus amyloid-negative amnestic mild cognitive impairment patients.

Authors:  Clémence Tomadesso; Vincent de La Sayette; Robin de Flores; Pierrick Bourgeat; Victor L Villemagne; Stéphanie Egret; Francis Eustache; Gaël Chételat
Journal:  Alzheimers Dement (Amst)       Date:  2018-03-17

8.  18F-THK5351 PET Positivity and Longitudinal Changes in Cognitive Function in β-Amyloid-Negative Amnestic Mild Cognitive Impairment.

Authors:  Min Young Chun; Jongmin Lee; Jee Hyang Jeong; Jee Hoon Roh; Seung Jun Oh; Minyoung Oh; Jungsu S Oh; Jae Seung Kim; Seung Hwan Moon; Sook-Young Woo; Young Ju Kim; Yeong Sim Choe; Hee Jin Kim; Duk L Na; Hyemin Jang; Sang Won Seo
Journal:  Yonsei Med J       Date:  2022-03       Impact factor: 2.759

9.  Low Subicular Volume as an Indicator of Dementia-Risk Susceptibility in Old Age.

Authors:  Sonja M Kagerer; Clemens Schroeder; Jiri M G van Bergen; Simon J Schreiner; Rafael Meyer; Stefanie C Steininger; Laetitia Vionnet; Anton F Gietl; Valerie Treyer; Alfred Buck; Klaas P Pruessmann; Christoph Hock; Paul G Unschuld
Journal:  Front Aging Neurosci       Date:  2022-03-03       Impact factor: 5.750

10.  Longitudinal outcomes of amyloid positive versus negative amnestic mild cognitive impairments: a three-year longitudinal study.

Authors:  Byoung Seok Ye; Hee Jin Kim; Yeo Jin Kim; Na-Yeon Jung; Jin San Lee; Juyoun Lee; Young Kyoung Jang; Jin-Ju Yang; Jong-Min Lee; Jacob W Vogel; Duk L Na; Sang Won Seo
Journal:  Sci Rep       Date:  2018-04-03       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.